“…Western blotting was conducted with commercially available antibodies [21,28,30,31]. Primary antibodies directed against the following proteins were purchased from the indicated sources: Akt (1:1000, #9272) [26], phospho-Akt (1:1000, Ser-473, #9721) [26], CaMKII (1:1000, #3362) [32], phospho-CaMKII (1:1000, Thr-286, #3361) [32], BAX (1:1000, #2772) [21], LC3 (1:1000, #12741) [21], Bcl-2 (1:1000, #3498) [28], phospho-mTOR (1:1000, Ser-2448, #5536; Ser-2481, #2974) [26], mTOR (1:1000, #2972) [26] and RIP3 (1:1000, #95702) [33] from Cell Signaling Technology (Boston, MA, USA), p62 (#PM045) from MBL (Nagoya, Japan), and GAPDH (sc-25778) [26] from Santa Cruz Biotechnology (Santa Cruz, CA, USA), phosphorylated phospholamban (PLN) (1:5000, phospho-Ser-16, #A010-12; 1:1000, phospho-Thr-17, #A010-13) [21] and PLN (1:2000, #A010-14) [21] from Badrilla (Leeds, UK).…”